All lobbying filings

Aviva Strategies (FKA MGB Consulting)

Aviva Strategies (FKA MGB Consulting) filed a Q1 report for Element Biosciences on April 17, 2026, reporting $39,000 in lobbying income.

Lobbying for Element Biosciences · Biotechnology

As filed: AVIVA STRATEGIES (FKA MGB CONSULTING) for ELEMENT BIOSCIENCES.

All filings by Aviva Strategies (FKA MGB Consulting) · Everything Element Biosciences has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$39,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025

Medical/Disease Research/Clinical Labs

- National Security Commission on Emerging Biotechnology

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.